Association between activated clotting time and TIMI flow in STEMI patients pre-treated with unfractionated heparin


Por: Cañedo, E, Carrillo-Suárez, X, Fernández-Nofrerías, E, Rodríguez-Leor, O, Grau, EF, Vilalta, V, Trichilo, M, Giralt, T, Bayés-Genís, A and Santos-Pardo, I

Publicada: 1 feb 2026 Ahead of Print: 1 nov 2025
Resumen:
Background: Early patency in the infarct-related artery (IRA) in patients with STEMI is associated with reduced mortality. Pretreatment with unfractionated heparin (UFH) is standard in many STEMI networks. Whether a specific Activated Clotting Time (ACT) value predicts the IRA's flow restoration remains unclear. Our main aims were to assess the relationship between initial ACT and Thrombolysis in Myocardial Infarction (TIMI) flow 2-3 in STEMI patients pretreated with UFH and to develop a predictive model for early IRA reperfusion based on ACT. Methods: We conducted a retrospective, single-centre study of 898 consecutive STEMI patients from the Codi-IAM network (Catalonia, Spain) between 2015 and 2023. All subjects received 5000 units of UFH within 120 min of symptom onset. ACT was measured at arterial catheterisation, and IRA-TIMI flow was assessed during diagnostic angiography. Median ACT values were compared, and a logistic regression model with bootstrap variable selection identified independent predictors of TIMI 2-3 flow. Model performance was evaluated using ROC curves and the Brier score. Results: Median ACT was 180 s (163-200) in patients with TIMI 0-1 and 185 s (168-203) in those with flow TIMI 2-3. Higher ACT, diabetes, shorter time to heparin administration, and absence of hypertension were independently associated with TIMI 2-3 flow. However, ACT showed modest discrimination (area under the curve = 0.612), limiting its predictive value. Conclusions: ACT measured on arrival did not reliably predict IRA patency in STEMI patients pretreated with 5000 units of UFH.

Filiaciones:
Cañedo, E:
 Germans Trias & Pujol Univ Hosp, Heart Inst, Unit Cardiovasc Intervent, Badalona, Spain

:
 Germans Trias & Pujol Univ Hosp, Heart Inst, Unit Cardiovasc Intervent, Badalona, Spain

Fernández-Nofrerías, E:
 Germans Trias & Pujol Univ Hosp, Heart Inst, Unit Cardiovasc Intervent, Badalona, Spain

:
 Germans Trias & Pujol Univ Hosp, Heart Inst, Unit Cardiovasc Intervent, Badalona, Spain

Grau, EF:
 Germans Trias & Pujol Univ Hosp, Heart Inst, Unit Cardiovasc Intervent, Badalona, Spain

Vilalta, V:
 Germans Trias & Pujol Univ Hosp, Heart Inst, Unit Cardiovasc Intervent, Badalona, Spain

Trichilo, M:
 Germans Trias & Pujol Univ Hosp, Heart Inst, Unit Cardiovasc Intervent, Badalona, Spain

Giralt, T:
 Hosp Mar, Dept Cardiol, Barcelona, Spain

 Univ Pompeu Fabra, Dept Med, Barcelona, Spain

:
 Germans Trias & Pujol Univ Hosp, Heart Inst, Unit Cardiovasc Intervent, Badalona, Spain

:
 Germans Trias & Pujol Univ Hosp, Heart Inst, Unit Cardiovasc Intervent, Badalona, Spain

 Karolinska Inst, Dept Clin Sci & Educ, Unit Cardiol, Sodersjukhuset, Stockholm, Sweden
ISSN: 01675273





International Journal of Cardiology
Editorial
Elsevier BV, ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND, Países Bajos
Tipo de documento: Article
Volumen: 444 Número:
Páginas: 134007-134007
WOS Id: 001621607400001
ID de PubMed: 41241194

MÉTRICAS